In vivo induction of cutaneous inflammation results in the accumulation of extracellular trap-forming neutrophils expressing RORγt and IL-17

Journal of Investigative Dermatology

Volumn 134, Issue 5, 2014, Pages 1276-1284

  Keijsers, Romy R M C ^a   Hendriks, Anke G M ^a   Van Erp, Piet E J ^a   Van Cranenbroek, Bram ^a   Van De Kerkhof, Peter C M ^a   Koenen, Hans J P M ^a   Joosten, Irma ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; ELASTASE; INTERLEUKIN 17; LEUKOTRIENE B4; RETINOID RELATED ORPHAN RECEPTOR GAMMA; TRANSCRIPTION FACTOR FOXP3; TRYPTASE; MESSENGER RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ROR GAMMA T; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL DIFFERENTIATION; DERMATITIS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MAST CELL; NEUTROPHIL; NORMAL HUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PSORIASIS; REGULATORY T LYMPHOCYTE; SKIN BIOPSY; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; CELL POPULATION; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; EXTRACELLULAR SPACE; HUMAN CELL; HUMAN TISSUE; HYPERKERATOSIS; INNATE IMMUNITY; PRIORITY JOURNAL; TH17 CELL;

ADAPTIVE IMMUNITY; ADOLESCENT; ADULT; BIOPSY; DERMATITIS; FEMALE; HEALTHY VOLUNTEERS; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-17; LEUKOTRIENE B4; MALE; MAST CELLS; MIDDLE AGED; NEUTROPHILS; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; PSORIASIS; SKIN; SURGICAL TAPE; T-LYMPHOCYTES, REGULATORY; YOUNG ADULT;

EID: 84900868717     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2013.526     Document Type: Article

References (39)

1. Appel H, Maier R, Wu P et al. (2011) Analysis of IL-17(+) cells in facet joints of patients with spondyloarthritis suggests that the innate immune pathway might be of greater relevance than the Th17-mediated adaptive immune response. Arthritis Res Ther 13:R95
2. Bovenschen HJ, van de Kerkhof PC, van Erp PE et al. (2011) Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17Aproducing cells and are found in lesional skin. J Investig Dermatol Symp Proc 131:1853-60
3. Bradley PP, Priebat DA, Christensen RD et al. (1982) Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker. J Investig Dermatol Symp Proc 78:206-9
4. Brinkmann V, Reichard U, Goosmann C et al. (2004) Neutrophil extracellular traps kill bacteria. Science 303:1532-5
5. Cai Y, Shen X, Ding C et al. (2011) Pivotal role of dermal IL-17-producing gammadelta T cells in skin inflammation. Immunity 35:596-610
6. Camp R, Jones RR, Brain S et al. (1984) Production of intraepidermal microabscesses by topical application of leukotriene B4. J Investig Dermatol Symp Proc 82:202-4
7. Chang A, de Jongh GJ, Mier PD et al. (1988) Enzymatic quantification of polymorphonuclear leucocytes in normal and psoriatic skin following standardized injury. Clin Exp Dermatol 13:62-6
8. Chen X, Oppenheim JJ (2011) Resolving the identity myth: Key markers of functional CD4+FoxP3+ regulatory T cells. Int Immunopharmacol 11: 1489-96
9. de Jong EM, van Erp PE, van Vlijmen IM et al. (1992) The inter-relation between inflammation and epidermal proliferation in normal skin following epicutaneous application of leukotriene-B4-An immunohistochemical study. Clin Exp Dermatol 17:413-20
10. de Mare S, van Erp PE, Ramaekers FC et al. (1990) Flow cytometric quantification of human epidermal cells expressing keratin 16 in vivo after standardized trauma. Arch Dermatol Res 282:126-30
11. Dudda JC, Perdue N, Bachtanian E et al. (2008) Foxp3+ regulatory T cells maintain immune homeostasis in the skin. J Exp Med 205:1559-65
12. Friedrich EB, Tager AM, Liu E et al. (2003) Mechanisms of leukotriene B4-Triggered monocyte adhesion. Arteriosclerosis, Thrombosis Vascular Biol 23:1761-7
13. Funk CD (2001) Prostaglandins and leukotrienes: Advances in eicosanoid biology. Science 294:1871-5
14. Gerritsen MJ, van Erp PE, van Vlijmen-Willems IM et al. (1994) Repeated tape stripping of normal skin: A histological assessment and comparison with events seen in psoriasis. Arch Dermatol Res 286:455-61
15. Horwitz M, Benson KF, Person RE et al. (1999) Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis. Nat Genet 23:433-6
16. Hueber W, Patel DD, Dryja T et al. (2010) Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis. Sci Transl Med 2:52ra72
17. Keijsers RR, van der Velden HM, van Erp PE et al. (2013) Balance of Treg versus T-helper cells in the transition from symptomless to lesional psoriatic skin. Br J Dermatol 168:1294-302
18. Korn T, Bettelli E, Oukka M et al. (2009) IL-17 and Th17 Cells. Ann Rev Immunol 27:485-517
19. Krueger JG (2012) Hiding under the skin: A welcome surprise in psoriasis. Nat Med 18:1750-1
20. Lammers AM, van de Kerkhof PC, Schalwijk J et al. (1986) Elastase, a marker for neutrophils in skin infiltrates. Br J Dermatol 115:181-6
21. Leonardi C, Matheson R, Zachariae C et al. (2012) Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis. New England J Med 366:1190-9
22. Lewis RA, Austen KF, Soberman RJ (1990) Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. New England J Med 323:645-55
23. Lin AM, Rubin CJ, Khandpur R et al. (2011) Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis. J Immunol 187: 490-500
24. Mak RK, Hundhausen C, Nestle FO (2009) Progress in understanding the immunopathogenesis of psoriasis. Actas Dermo-sifiliograficas 100(Suppl 2):2-13
25. Murphy RC, Gijon MA (2007) Biosynthesis and metabolism of leukotrienes. Biochem J 405:379-95
26. Nestle FO, Kaplan DH, Barker J (2009) Psoriasis. New England J Med 361: 496-509
27. Noordenbos T, Yeremenko N, Gofita I et al. (2012) Interleukin-17-positive mast cells contribute to synovial inflammation in spondylarthritis. Arthritis Rheum 64:99-109
28. Pantelyushin S, Haak S, Ingold B et al. (2012) Rorgammat+ innate lymphocytes and gammadelta T cells initiate psoriasiform plaque formation in mice. J Clin Invest 122:2252-6
29. Papp KA, Leonardi C, Menter A et al. (2012) Brodalumab, an antiinterleukin-17-receptor antibody for psoriasis. New England J Med 366:1181-9
30. Rajadhyaksha M, Gonzalez S, Zavislan JM et al. (1999) In vivo confocal scanning laser microscopy of human skin II: Advances in instrumentation and comparison with histology. J Investig Dermatol Symp Proc 113: 293-303
31. Rajadhyaksha M, Grossman M, Esterowitz D et al. (1995) In vivo confocal scanning laser microscopy of human skin: Melanin provides strong contrast. J Investig Dermatol Symp Proc 104:946-52
32. Ruzicka T, Simmet T, Peskar BA et al. (1986) Skin levels of arachidonic acidderived inflammatory mediators and histamine in atopic dermatitis and psoriasis. J Investig Dermatol Symp Proc 86:105-8
33. Suurmond J, Dorjee AL, Boon MR et al. (2011) Mast cells are the main interleukin 17-positive cells in anticitrullinated protein antibody-positive and-negative rheumatoid arthritis and osteoarthritis synovium. Arthritis Res Ther 13:R150
34. Tomura M, Honda T, Tanizaki H et al. (2010) Activated regulatory T cells are the major T cell type emigrating from the skin during a cutaneous immune response in mice. J Clin Invest 120:883-93
35. Tsoi LC, Spain SL, Knight J et al. (2012) Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat Genet 44:1341-8
36. von Kockritz-Blickwede M, Goldmann O, Thulin P et al. (2008) Phagocytosisindependent antimicrobial activity of mast cells by means of extracellular trap formation. Blood 111:3070-80
37. Wartha F, Henriques-Normark B (2008) ETosis: A novel cell death pathway. Sci Signaling 1:pe25
38. Yokomizo T, Izumi T, Shimizu T (2001) Leukotriene B4: Metabolism and signal transduction. Arch Biochem Biophys 385:231-41
39. Ziboh VA, Casebolt TL, Marcelo CL et al. (1984) Biosynthesis of lipoxygenase products by enzyme preparations from normal and psoriatic skin. J Investig Dermatol Symp Proc 83:426-30